Table 2 Site-specific clinical parameters evaluated in groups I and II

SS-PPD^$ (mm)

Mean±SD

8.2±1.3

1.39±0.49

P <0.01^**

Median (Q1–Q3)

7.80 (7.5–8.6)

1.30 (1.0–2.0)

SS-CAL^$ (mm)

Mean±SD

10.87±1.82

0

P <0.01^**

Median (Q1–Q3)

10.30 (9.6–11.3)

0

SS-PI^$

Mean±SD

1.86 ± 0.26

0.65±0.18

P <0.01^**

Median (Q1–Q3)

2.0 (1.75–2.0)

0.75 (0.75–0.75)

SS-GI^$

Mean±SD

1.24±0.28

0.17±0.19

P <0.01^**

Median (Q1–Q3)

1.0 (1.0–1.0)

0.25 (0–0.25)